- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03175809
Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain
Pelvic Floor Muscle Training With or Without Dry Needling for Women With Chronic Pelvic Pain: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic pelvic pain (CPP) is characterized as non-cyclic pain located in the distal region of the abdomen and pelvis, often refractory to conventional treatments, lasting more than six months The presence of trigger points in the pelvic floor muscles (PFM) is a frequent condition in individuals with CPP and is associated with higher levels of pain, disability and functional decline. Secondary dysfunctions associated with the clinical picture of chronic pelvic pain can be treated with muscle training through the use of biofeedback and dry needling. The purpose of this study is to test the effectiveness of two interventions: pelvic floor muscle (PFM) training with biofeedback and PFM training with the addition of trigger point dry needling applied over(Lumbar square, psoas, external obliques, gluteus medius, piriformis and adductors) on pain and quality of life of women with CPP.
We will recruit 44 women aged 18 to 60 years with CPP lasting for a minimum of six months. We will exclude women with urinary incontinence, neurological conditions, malignancy, fractures, pregnancy and those that did not agree to receive treatment with needles will be excluded.
Individuals will be randomized into two groups: PFM training with biofeedback and Dry Needling Group and PFM training with biofeedback. Participants will receive a total of 4 sessions twice a week,,for two weeks. This investigation's primary outcome will be pain (NRS) Immediately after the 4 visits. Quality of life, global impression of recovery and sexual function evaluated at Immediately after the 4 visits will be secondary outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marcelo F Silva, Doctor
- Phone Number: 8876 55 51 33039000
- Email: marcelofs@ufcspa.edu.br
Study Locations
-
-
RS
-
Porto Alegre, RS, Brazil, 90050-170
- Universidade Federal de Ciências da Saúde de Porto Alegre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women
- Aged between 18 and 60 years
- Pain in the lower pelvic and lumbar region, are not related to filling or emptying of the bladder, for more than 6 months
- With medical diagnosis of CPP
Exclusion Criteria:
- Previous spinal surgery
- Any neurological condition
- Cancer,
- Fractures in the pelvic region and or lumbar spine
- Lumbar radiculopathy.
- Pregnancy
- Women with difficulty in understanding written or spoken language
- Having urinary infection or appendicitis on the day of evaluation,
- Who are diagnosed with Post-coital bleeding, postmenopausal bleeding, unexplained abrupt weight loss, presence of visible mass on ultrasound, macroscopic or microscopic hematuria.
- Performed some surgical intervention with general anesthesia in the last 120 days,
- Having being received Intervesical therapy or botox in the last 90 days,
- Aversion / phobia to needles .
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: PFM training
4 sessions (40 minutes approximately), Twice a week for 2 weeks of pelvic floor training with electromyographic biofeedback.
|
The PFM training will be delivered with an electromyographic biofeedback (bEMG).
In order to perform the muscular training, the Biotrainer software was used, the training protocol will follow a rationale of evolutionary complexity throughout each session.
The training protocols will focus on both muscle relaxation and contraction training and coordination.The parameters for the biofeedback will be tailored to the participant's presentation and will be determined and adjusted between each session as needed by the treating therapist.
The treatment parameters will be determined by the treating therapist based on the participant's assessment that will be conducted at each treatment session.
The Maximum voluntary contraction will be assessed at the beginning of each training day.
|
Experimental: PFM training plus dry needling
PFM training associated with the use of dry needling over abdominal, gluteal and lombar miofascial trigger points.
|
The PFM training will be delivered with an electromyographic biofeedback (bEMG).
In order to perform the muscular training, the Biotrainer software was used, the training protocol will follow a rationale of evolutionary complexity throughout each session.
The training protocols will focus on both muscle relaxation and contraction training and coordination.The parameters for the biofeedback will be tailored to the participant's presentation and will be determined and adjusted between each session as needed by the treating therapist.
The treatment parameters will be determined by the treating therapist based on the participant's assessment that will be conducted at each treatment session.
The Maximum voluntary contraction will be assessed at the beginning of each training day.
The dry needling technique will be applied to the abdominal muscles (external oblique, rectus abdominis), lumbar spine (lumbar multifidus and erector spinae) and hip muscles (piriformis, gluteus medius, psoas major and adductors).
Both active of latent myofascial trigger points will be treated with sterile stainless steel needles (0.25x0.4 mm or 0.2x0,7mm, DongBang, Korea).
After diagnosis of the area of muscle pain, the tight band of the muscle will be palpated and the needle will be introduced subcutaneously.
The second insertion will be toward the muscle point until a local twitch response (LTR) is elicited.
Then the needle will be removed and the area will be compressed for 30 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pelvic Pain
Time Frame: Two weeks after randomization
|
Numerical Pain rating scale (0-10)
|
Two weeks after randomization
|
Pelvic Pain
Time Frame: Four weeks after randomization
|
Numerical Pain rating scale (0-10)
|
Four weeks after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sexual dysfunction
Time Frame: Two weeks after randomization
|
female sexual dysfunction index (IFSF)
|
Two weeks after randomization
|
Sexual dysfunction
Time Frame: Four weeks after randomization
|
female sexual dysfunction index (IFSF)
|
Four weeks after randomization
|
Quality of life of Volunteers
Time Frame: Two weeks after randomization
|
SF-12
|
Two weeks after randomization
|
Satisfaction referred by the volunteers with the treatment
Time Frame: Two weeks after randomization
|
self-reported satisfsction with treatment (0-10)
|
Two weeks after randomization
|
Quality of life of Volunteers
Time Frame: Four weeks after randomization
|
SF-12
|
Four weeks after randomization
|
Satisfaction referred by the volunteers with the treatment
Time Frame: Four weeks after randomization
|
self-reported satisfsction with treatment (0-10)
|
Four weeks after randomization
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mariana D Valentina Pessoa, PT, Federal University of Health Science of Porto Alegre
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUHSPortoAlegremvp
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pelvic Pain
-
Nantes University HospitalTerminatedChronic Pelvic Pain | Chronic Perineal PainFrance
-
University of California, San FranciscoStanford University; National Center for Complementary and Integrative Health...CompletedPelvic Pain | Chronic Pelvic Pain | Recurrent Pelvic PainUnited States
-
Istanbul UniversityCompletedChronic Pelvic Pain SyndromeTurkey
-
RAPbarcelonaCompletedChronic Pain | Pelvic Pain | Physical Therapy | Chronic Pain Syndrome | Pelvic Pain Syndrome | Chronic Pelvic Inflammatory DiseaseSpain
-
Queen Mary University of LondonHeadspace UKCompletedChronic Pelvic PainUnited Kingdom
-
Göteborg UniversityCompletedChronic Pelvic PainSweden
-
Northwestern UniversityRecruiting
-
Guang'anmen Hospital of China Academy of Chinese...Not yet recruitingChronic Pelvic Pain
-
Ministry of Health and Population, EgyptUnknown
-
Universidad de GranadaCompleted
Clinical Trials on PFM training
-
Shanghai Institute of Acupuncture, Moxibustion...CompletedStress Urinary IncontinenceChina
-
Shanghai Institute of Acupuncture, Moxibustion...CompletedUrinary IncontinenceChina
-
University of AlcalaCompleted
-
Cairo UniversityUnknownPEEK Implant Supported Restoration
-
Riphah International UniversityCompleted
-
University of ZurichITI FoundationActive, not recruitingImplant-supported Single CrownsSwitzerland
-
Baxalta now part of ShireBaxter BioScienceCompleted
-
Baxalta now part of ShireCompleted
-
Yeditepe UniversityTugtepe Pediatric Urology ClinicCompletedLower Urinary Tract SymptomsTurkey
-
Federal University of São PauloCompleted